College of Veterinary Medicine
Sahay Lab
Led by Bikash Sahay · Infectious Diseases and Immunology
What we study
The lab studies gut microbes and their role in health and disease, focusing on using microbes or their products to treat ailments like infections. They develop vaccines and explore the complex microbial communities in the human gut.
What working here is like
- Bacteria & microbes
- Project
- 1
- Papers
- 4
Current projects
Fusobacterium epitope targeted Oral vaccine for OSCC
Developing an oral vaccine targeting Fusobacterium to treat oral squamous cell carcinoma.
Summaries are written by AI in plain language from public symposium abstracts and may be imperfect.
Recent papers, explained
- Antiviral Role of Surface Layer Protein A (SlpA) of Lactobacillus acidophilus
2026 · Pathogens
Shows that SlpA from Lactobacillus acidophilus triggers antiviral genes in human cells.
- Identification and Expression of Immunogenic Mimotopes of C. hepaticus Using an E. coli-Based Surface Display System
2026 · Vaccines
Identifies and expresses vaccine candidates from Campylobacter hepaticus on an E. coli vector.
Show 2 more papersShow fewer
- Polymicrobial periodontal infection selectively alters the fecal microbiome in mice: Implications for the oral-gut microbial axis
2026 · Archives of Oral Biology
- R-5780, a SagA-engineered Lactococcus lactis, is a safe oral synthetic-biology microbial therapy that potentiates PD-1 blockade
2026 · Cancer Immunology Immunotherapy
Tests whether a modified Lactococcus lactis strain can boost PD-1 immunotherapy in mice with colorectal cancer.
Plain-language summaries are AI-written and reviewed by us; check the paper for details.
How to reach out
Bikash Sahay hasn't set up this page yet. You can also look them up in the UF directory (search “Bikash Sahay”).